These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 22796782

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chitosan/poly (lactic acid)-coated piceatannol nanoparticles exert an in vitro apoptosis activity on liver, lung and breast cancer cell lines.
    Dhanapal J, Balaraman Ravindrran M.
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):274-282. PubMed ID: 29298541
    [Abstract] [Full Text] [Related]

  • 3. Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug.
    Wang W, Chen S, Zhang L, Wu X, Wang J, Chen JF, Le Y.
    Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():514-20. PubMed ID: 25492016
    [Abstract] [Full Text] [Related]

  • 4. Enhanced anti-topoisomerase II activity by mucoadhesive 4-CBS-chitosan/poly (lactic acid) nanoparticles.
    Songsurang K, Suvannasara P, Phurat C, Puthong S, Siraleartmukul K, Muangsin N.
    Carbohydr Polym; 2013 Nov 06; 98(2):1335-42. PubMed ID: 24053811
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM, Alomrani AH, Harisa GI, Ashour AE, Kumar A, Yassin AE.
    Biomed Pharmacother; 2018 Oct 06; 106():1461-1468. PubMed ID: 30119220
    [Abstract] [Full Text] [Related]

  • 7. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS, Mei L, Anitha P, Gan CW, Zhou W.
    Biomaterials; 2009 Jul 06; 30(19):3297-306. PubMed ID: 19299012
    [Abstract] [Full Text] [Related]

  • 8. Toxic effects of aflatoxin B1 on embryonic development of zebrafish (Danio rerio): potential activity of piceatannol encapsulated chitosan/poly (lactic acid) nanoparticles.
    Dhanapal J, Ravindrran MB, Baskar SK.
    Anticancer Agents Med Chem; 2015 Jul 06; 15(2):248-57. PubMed ID: 25322988
    [Abstract] [Full Text] [Related]

  • 9. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system.
    Arif M, Raja MA, Zeenat S, Chi Z, Liu C.
    J Biomater Sci Polym Ed; 2017 Jan 06; 28(1):50-62. PubMed ID: 27691398
    [Abstract] [Full Text] [Related]

  • 10. [PLA-O-CMC nanoparticles: HGF loading and delivery behaviors in vitro].
    Li Z, Chen Z, Chang R.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr 06; 28(2):314-7. PubMed ID: 21604493
    [Abstract] [Full Text] [Related]

  • 11. [Preparation and in vitro evaluation of brucine-loaded polylacticacid nanoparticles].
    Zhao J, Liu Z, Xu J, Yu Y, Feng N.
    Zhongguo Zhong Yao Za Zhi; 2009 Sep 06; 34(18):2322-4. PubMed ID: 20030079
    [Abstract] [Full Text] [Related]

  • 12. Antitumor effect of poly lactic acid nanoparticles loaded with cisplatin and chloroquine on the oral squamous cell carcinoma.
    Li Q, Liu X, Yan W, Chen Y.
    Aging (Albany NY); 2020 Dec 11; 13(2):2593-2603. PubMed ID: 33323546
    [Abstract] [Full Text] [Related]

  • 13. Formation and characterization of chitosan-polylacticacid-polyethylene glycol-gelatin nanoparticles: a novel biosystem for controlled drug delivery.
    Rajan M, Raj V.
    Carbohydr Polym; 2013 Oct 15; 98(1):951-8. PubMed ID: 23987433
    [Abstract] [Full Text] [Related]

  • 14. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ.
    Colloids Surf B Biointerfaces; 2016 Feb 01; 138():1-9. PubMed ID: 26638176
    [Abstract] [Full Text] [Related]

  • 15. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
    Han S, Liu Y, Nie X, Xu Q, Jiao F, Li W, Zhao Y, Wu Y, Chen C.
    Small; 2012 May 21; 8(10):1596-606. PubMed ID: 22411637
    [Abstract] [Full Text] [Related]

  • 16. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.
    Zhang X, Liu L, Chai G, Zhang X, Li F.
    Drug Dev Ind Pharm; 2013 Nov 21; 39(11):1618-24. PubMed ID: 24087853
    [Abstract] [Full Text] [Related]

  • 17. Anti-cancer evaluation of quercetin embedded PLA nanoparticles synthesized by emulsified nanoprecipitation.
    Pandey SK, Patel DK, Thakur R, Mishra DP, Maiti P, Haldar C.
    Int J Biol Macromol; 2015 Apr 21; 75():521-9. PubMed ID: 25701491
    [Abstract] [Full Text] [Related]

  • 18. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
    Li Y, Wu H, Yang X, Jia M, Li Y, Huang Y, Lin J, Wu S, Hou Z.
    Mol Pharm; 2014 Aug 04; 11(8):2915-27. PubMed ID: 24984984
    [Abstract] [Full Text] [Related]

  • 19. Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis.
    Elbaz NM, Khalil IA, Abd-Rabou AA, El-Sherbiny IM.
    Int J Biol Macromol; 2016 Nov 04; 92():254-269. PubMed ID: 27397719
    [Abstract] [Full Text] [Related]

  • 20. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S, Rabanel JM, Hildgen P.
    Int J Pharm; 2011 Jun 15; 411(1-2):178-87. PubMed ID: 21458551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.